Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar ayuddha (< 20) Submitted: 7/16/2012 3:17:23 AM : Outperform Start Price: $11.35 ARNA Score: -48.92

It was picked by www.hechtsoft.de Trade Alerts.

Featured Broker Partners


Advertisement